Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124521063 | 12452106 | 3 | F | 20151202 | 20160831 | 20160609 | 20160914 | EXP | US-ACORDA-ACO_124917_2016 | ACORDA | 53.38 | YR | F | Y | 48.71000 | KG | 20160914 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124521063 | 12452106 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 22250 | 10 | MG | TABLET | BID | ||||||
| 124521063 | 12452106 | 2 | C | TECFIDERA | DIMETHYL FUMARATE | 1 | Oral | 240 MG, BID | 346080 | MG | U | 0 | 240 | MG | BID | ||||
| 124521063 | 12452106 | 3 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 50 MG, 2 QID PRN | U | 0 | 50 | MG | |||||||
| 124521063 | 12452106 | 4 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 230 MCG-21 MCG/INHALATION AEROSOL, 2 PUFFS BID | U | 0 | |||||||||
| 124521063 | 12452106 | 5 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 60 MG, QD | U | 0 | 60 | MG | QD | ||||||
| 124521063 | 12452106 | 6 | C | DALIRESP | ROFLUMILAST | 1 | Oral | 500 ?G, QD | U | 0 | 500 | UG | QD | ||||||
| 124521063 | 12452106 | 7 | C | FENTANYL. | FENTANYL | 1 | Transdermal | 25 ?G/HR, Q 3 DAYS | U | 0 | 25 | UG | |||||||
| 124521063 | 12452106 | 8 | C | FIORINAL WITH CODEINE | ASPIRINBUTALBITALCAFFEINECODEINE PHOSPHATE | 1 | Oral | 1 DF, BID PRN | U | 0 | 1 | DF | CAPSULE | BID | |||||
| 124521063 | 12452106 | 9 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | 0.05 MG, 2 SPRAYS BID | U | 0 | .05 | MG | |||||||
| 124521063 | 12452106 | 10 | C | HYDROXYZINE HYDROCHLORIDE. | HYDROXYZINE HYDROCHLORIDE | 1 | Oral | 25 MG, QID PRN | U | 0 | 25 | MG | QID | ||||||
| 124521063 | 12452106 | 11 | C | HYDROXYZINE PAMOATE. | HYDROXYZINE PAMOATE | 1 | Oral | 50 MG, QID PRN | U | 0 | 50 | MG | QID | ||||||
| 124521063 | 12452106 | 12 | C | HYDROXYZINE PAMOATE. | HYDROXYZINE PAMOATE | 1 | U | 0 | |||||||||||
| 124521063 | 12452106 | 13 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | Oral | 200 MG, HS | U | 0 | 200 | MG | QD | ||||||
| 124521063 | 12452106 | 14 | C | LASIX | FUROSEMIDE | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 124521063 | 12452106 | 15 | C | LEVETIRACETAM. | LEVETIRACETAM | 1 | Oral | 1000 MG, 1.5 TABLET BID | U | 0 | 1000 | MG | TABLET | ||||||
| 124521063 | 12452106 | 16 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 25 MG, QD | U | 0 | 25 | MG | QD | ||||||
| 124521063 | 12452106 | 17 | C | MELOXICAM. | MELOXICAM | 1 | Oral | 15 MG, QD | U | 0 | 15 | MG | QD | ||||||
| 124521063 | 12452106 | 18 | C | MIRAPEX | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | Oral | 0.25 MG, HS | U | 0 | .25 | MG | QD | ||||||
| 124521063 | 12452106 | 19 | C | MUCINEX | GUAIFENESIN | 1 | Unknown | 1200 MG, BID | U | 0 | 1200 | MG | BID | ||||||
| 124521063 | 12452106 | 20 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 10MG-325MG, PRN | U | 0 | |||||||||
| 124521063 | 12452106 | 21 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 124521063 | 12452106 | 22 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | QD | ||||||
| 124521063 | 12452106 | 23 | C | SOMA | CARISOPRODOL | 1 | Oral | 350 MG, TID | U | 0 | 350 | MG | TID | ||||||
| 124521063 | 12452106 | 24 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 18 ?G, QAM INHALATION | U | 0 | 18 | UG | QD | |||||||
| 124521063 | 12452106 | 25 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 100 MG, HS | U | 0 | 100 | MG | QD | ||||||
| 124521063 | 12452106 | 26 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0.5 MG, BID ONE QAM AND ONE AT NOON | U | 0 | .5 | MG | BID | ||||||
| 124521063 | 12452106 | 27 | C | ZYPREXA | OLANZAPINE | 1 | Oral | 2.5 MG, QD | U | 0 | 2.5 | MG | QD | ||||||
| 124521063 | 12452106 | 28 | C | MEDROL | METHYLPREDNISOLONE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124521063 | 12452106 | 1 | Relapsing-remitting multiple sclerosis |
| 124521063 | 12452106 | 2 | Product used for unknown indication |
| 124521063 | 12452106 | 3 | Pain |
| 124521063 | 12452106 | 4 | Product used for unknown indication |
| 124521063 | 12452106 | 5 | Product used for unknown indication |
| 124521063 | 12452106 | 6 | Product used for unknown indication |
| 124521063 | 12452106 | 7 | Product used for unknown indication |
| 124521063 | 12452106 | 8 | Product used for unknown indication |
| 124521063 | 12452106 | 9 | Product used for unknown indication |
| 124521063 | 12452106 | 10 | Product used for unknown indication |
| 124521063 | 12452106 | 11 | Pruritus |
| 124521063 | 12452106 | 12 | Anxiety |
| 124521063 | 12452106 | 13 | Product used for unknown indication |
| 124521063 | 12452106 | 14 | Product used for unknown indication |
| 124521063 | 12452106 | 15 | Product used for unknown indication |
| 124521063 | 12452106 | 16 | Product used for unknown indication |
| 124521063 | 12452106 | 17 | Product used for unknown indication |
| 124521063 | 12452106 | 18 | Product used for unknown indication |
| 124521063 | 12452106 | 19 | Product used for unknown indication |
| 124521063 | 12452106 | 20 | Product used for unknown indication |
| 124521063 | 12452106 | 21 | Product used for unknown indication |
| 124521063 | 12452106 | 22 | Product used for unknown indication |
| 124521063 | 12452106 | 23 | Product used for unknown indication |
| 124521063 | 12452106 | 24 | Product used for unknown indication |
| 124521063 | 12452106 | 25 | Product used for unknown indication |
| 124521063 | 12452106 | 26 | Product used for unknown indication |
| 124521063 | 12452106 | 27 | Product used for unknown indication |
| 124521063 | 12452106 | 28 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124521063 | 12452106 | HO |
| 124521063 | 12452106 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124521063 | 12452106 | Balance disorder | |
| 124521063 | 12452106 | Contraindicated product administered | |
| 124521063 | 12452106 | Dizziness | |
| 124521063 | 12452106 | Multiple sclerosis relapse | |
| 124521063 | 12452106 | Seizure | |
| 124521063 | 12452106 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124521063 | 12452106 | 1 | 20151202 | 0 | ||
| 124521063 | 12452106 | 2 | 20131212 | 20151202 | 0 |